Chemoinformaics analysis of 8-Dimethylallyllisetin
| Molecular Weight | 450.487 | nRot | 5 |
| Heavy Atom Molecular Weight | 424.279 | nRig | 23 |
| Exact Molecular Weight | 450.168 | nRing | 4 |
| Solubility: LogS | -2.849 | nHRing | 2 |
| Solubility: LogP | 6.332 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 59 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 33 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 17 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 20 |
| nHA | 7 | APOL | 66.3706 |
| nHD | 3 | BPOL | 32.1594 |
| QED | 0.328 |
| Synth | 3.494 |
| Natural Product Likeliness | 1.896 |
| NR-PPAR-gamma | 0.595 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.616 |
| Pgp-sub | 0.972 |
| HIA | 0.458 |
| CACO-2 | -4.907 |
| MDCK | 0.0000104 |
| BBB | 0.002 |
| PPB | 0.727562 |
| VDSS | 0.738 |
| FU | 0.285303 |
| CYP1A2-inh | 0.404 |
| CYP1A2-sub | 0.344 |
| CYP2c19-inh | 0.7 |
| CYP2c19-sub | 0.057 |
| CYP2c9-inh | 0.816 |
| CYP2c9-sub | 0.458 |
| CYP2d6-inh | 0.029 |
| CYP2d6-sub | 0.182 |
| CYP3a4-inh | 0.119 |
| CYP3a4-sub | 0.048 |
| CL | 8.732 |
| T12 | 0.345 |
| hERG | 0.002 |
| Ames | 0.045 |
| ROA | 0.953 |
| SkinSen | 0.854 |
| Carcinogencity | 0.631 |
| EI | 0.263 |
| Respiratory | 0.696 |
| NR-Aromatase | 0.798 |
| Antiviral | Yes |
| Prediction | 0.648392 |